🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
MULTISARC is a randomized multicenter study assessing whether high throughp...
Status
Completed
Location
Institut Bergonie
Start Date
2019-10-19
Trial ID
NCT03784014
The primary purpose of the study is to estimate the maximum tolerated dose ...
Status
Completed
Location
University of Colorado Dept. of Anschutz Cancer (3)
Start Date
2013-06
Trial ID
NCT01772797
The primary purpose of the study was to compare the antitumor activity of L...
Status
Completed
Location
Highlands Oncology Group
Start Date
2013-06-28
Trial ID
NCT01828112
Treatments Being Tested
A single-Arm, open-label, multi-center, phase I/II study in which the pharm...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-03-07
Trial ID
NCT02040870
Treatments Being Tested
To compare the efficacy and safety of ceritinib with standard first-line ch...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-07-09
Trial ID
NCT01828099
Treatments Being Tested
This is an, open-label, protocol designed to evaluate the activity of targe...
Status
Withdrawn
Location
UT Southwestern Medical Center
Start Date
2015-06
Trial ID
NCT02289144
Treatments Being Tested
This was a Phase Ib/II study of the ALK inhibitor ceritinib in combination ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-05-14
Trial ID
NCT02292550
Treatments Being Tested
The purpose of this study is to assess the Treatment Strategies and Surviva...
Status
Recruiting
Location
Yongchang Zhang
Start Date
2020-04-16
Trial ID
NCT04322890
Treatments Being Tested
A Phase I study to assess the systemic exposure, effiacy, and safety of 450...
Status
Completed
Location
Highlands Oncology Group
Start Date
2015-04-09
Trial ID
NCT02299505
Treatments Being Tested
The primary purpose of this study is to determine the differences in PFS fo...
Status
Completed
Location
EmpiraMed, Inc.
Start Date
2018-07-23
Trial ID
NCT03546894
Treatments Being Tested